BREAKING

Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 minutes ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 hour ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 2 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 5 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 5 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 6 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 6 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 6 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 minutes ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 hour ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 2 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 5 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 5 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 6 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 6 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 6 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago

ADVERTISEMENT

Market News

Biocept Inc (BIOC) Q4 2020 Earnings Call

Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021. Corporate Participants: Jody Cain — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director Analysts: Michael Okunewitch — Maxim Group — Analyst _________ To read the […]

$BIOC April 1, 2021 1 min read

Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021.

Corporate Participants:

Jody Cain — Investor Relations

Michael W. Nall — President and Chief Executive Officer

Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations

Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director

ADVERTISEMENT

Analysts:

Michael Okunewitch — Maxim Group — Analyst

_________

To read the full earnings call transcript, click here

ADVERTISEMENT